Table 1 Clinico-pathological characteristics of the overall series, and percentage of cases with positive CD133 expression
Characteristics | No. pts (%) | No. (%) of cases with positive CD133 expression | p valuea |
|---|---|---|---|
All cases | 160 | 50 (31.2) | Â |
Age (yrs) | Â | Â | Â |
   <65 | 113 (70.6) | 36 (31.9) |  |
   ≥ 65 | 47 (29.4) | 14 (29.8) | 0.8 |
FIGO Stage | Â | Â | Â |
I-II | 20 (12.5) | 6 (30.0) | Â |
III | 119 (74.4) | 39 (32.8) | Â |
IV | 21 (13.1) | 5 (23.8) | 0.7 |
Grade | Â | Â | Â |
G1-2 | 28 (17.4) | 7 (25.0) | Â |
G3 | 107 (66.8) | 34 (31.8) | 0.5 |
n.a. | 35 (21.8) | Â | Â |
Histotype | Â | Â | Â |
Serous | 115 (71.9) | 33 (28.7) | Â |
Other | 45 (28.1) | 17 (40.5) | 0.2 |
Residual tumor | Â | Â | Â |
Absent | 52 (32.5) | 19 (36.5) | Â |
Suboptimal | 40 (25.0) | 8 (20.0) | Â |
Exploratory laparotomy | 68 (42.5) | 23 (33.8) | 0.2 |
Response to treatment | Â | Â | Â |
Yes | 130 (81.2) | 43 (33.1) | Â |
No | 30 (18.8) | 7 (23.3) | 0.3 |